Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation

摘要

BackgroundIslet cell transplantation can cure type 1 diabetes (T1D), but only a minority of recipients remains insulin–independent in the following years. We tested the hypothesis that allograft rejection and recurrent autoimmunity contribute to this progressive loss of islet allograft function.